Insight Molecular Diagnostics Inc. (LON:0KCC)
London flag London · Delayed Price · Currency is GBP · Price in USD
5.57
-0.15 (-2.58%)
Feb 12, 2026, 3:42 PM GMT

LON:0KCC Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
135321632148118
Market Cap Growth
391.27%97.40%-48.69%-78.62%25.55%21.50%
Enterprise Value
124331112120116
Last Close Price
3.881.891.995.0631.7640.36
PS Ratio
41.2321.3013.7439.7491.06132.18
PB Ratio
-19.73-3.260.810.963.074.80
P/TBV Ratio
-----17.31
EV/Sales Ratio
38.3121.649.6015.0773.75130.37
Debt / Equity Ratio
-0.34-0.300.110.090.090.26
Debt / EBITDA Ratio
0.010.010.00---
Asset Turnover
0.080.030.020.010.020.03
Quick Ratio
2.471.411.381.852.500.89
Current Ratio
2.791.621.492.112.771.03
Return on Equity (ROE)
-23603.11%-910.86%-76.26%-35.52%-88.37%-93.07%
Return on Assets (ROA)
-28.44%-26.42%-15.91%-13.88%-13.82%-42.66%
Return on Capital Employed (ROCE)
-71.60%-83.60%-32.90%-32.80%-16.30%-70.00%
Earnings Yield
-33.49%-151.40%-134.52%-191.48%-32.03%-18.62%
FCF Yield
-13.19%-52.98%-114.30%-131.09%-19.08%-16.93%
Buyback Yield / Dilution
-148.58%-70.84%-38.10%-24.61%-35.80%-27.65%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.